Trial intelligence / Profile preview

Effect of sedation by propofol and midazolam on cognitive performance after hip surgery

IRCT20120915010841N19Phase 3Completed

Sponsor
Hamadan University of Medical Sciences
Start
Feb 2019
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of propofol and midazolam in cognitive disorder (CD) (2 arms), sponsored by Hamadan University of Medical Sciences. Primary endpoint: Postoperative cognitive performance. Started Feb 2019; status: completed.

02

Drugs

propofolmidazolam
03

Conditions

cognitive disorder (CD)

Beyond the preview

Go deeper on IRCT20120915010841N19.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20120915010841N19.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call